Vaccine Adverse Event Reporting System (VAERS) Publications

How to search articles by keyword

To search articles on this page by keyword, first click the “open all” tab to list all publications. Then use the “find on this page” function available in most browsers. On desktop, press CTL+F (PC) or CMD+F (Mac) on your keyboard. A “find” text box will open at the top or bottom of your browser. Type the word or phrase you want to search for.

Moro PL, Woo EL, Marquez P, Cano M. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019external icon Vaccine. 2020 Jul 21;S0264-410X(20)30907. Online ahead of print.

Suragh TA, Hibbs B, Marquez P, McNeil MM. Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018external icon Vaccine. 2020 May 6;38(21):3747-3751. Epub Apr 6.

Hause AM, Hesse EM, Ng C, Marquez P, McNeil MM, Omer SB. Association Between Vaccine Exemption Policy Change in California and Adverse Event Reporting.external icon Pediatr Infec Dis J., 2020 May; 39(5):369-373. Epub 2020 Mar 5.

Haber P, Moro PL, Ng C, Dores GM, Perez-Vilar S, Marquez PL, Cano M. Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥ 65 years, Vaccine Adverse Event Reporting System (VAERS), United States, September 2010 – December 2018.external icon Vaccine. 2020 Feb 5;38(6):1476-1480. Epub 2019 Dec 28.

Su JR, Haber P, Ng CS, Marquez PL, Dores GM, Perez-Vilar S, Cano MV. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.external icon Vaccine. 2020 Feb 11;38(7): 1746-1752. Epub 2019 Dec 20.

Hibbs BF, Ng CS, Museru O, Moro PL, Marquez P, Woo EJ, Cano MV, Shimabukuro TT. Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017.external icon Vaccine. 2020 Jan 29;38(5):1137-1143. Epub 2019 Nov 26.

Shimabukuro TT, Su JR, Marquez PL, Mba-Jonas A, Arana JE, Cano MV. Safety of the 9-Valent Human Papillomavirus Vaccine.external icon Pediatrics 2019 Dec; 144(6). pii: e20191791. Epub 2019 Nov 18.

Moro PL, McNeil MM. Challenges in evaluating post-licensure vaccine safety: observations from the Center for Disease Control and Prevention.external icon Expert Rev Vaccines. 2019 Oct; 18(10): 1091-1101 Epub 2019 Oct 19.

McNeil MM, Paradowska-Stankiewicz I, Miller ER, Marquez PL, Seshadri S, Collins LC Jr, Cano MV. Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011-July 2018.external icon Vaccine. 2019 Oct 16; 37(44): 6760-6767 Epub 2019 Sep 20.

Hesse EM, Hibbs BF, Cano MV. Notes from the Field: Administration of Expired Injectable Influenza Vaccines Reported to the Vaccine Adverse Event Reporting System — United States, July 2018–March 2019.external icon MMWR Morb Mortal Wkly Rep. 2019; 68: 529–530. 2019 June 14.

Moro PL, Arana J, Marquez PL, Ng C, Barash F, Hibbs BF, Cano M. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.external icon Vaccine. 2019 Jun 19; 37(28): 3730-3734. Epub 2019 May 30.

Kochhar S, Edwards KM, Ropero Alvarez AM, Moro PL, Ortiz JR. Introduction of new vaccines for immunization in pregnancy – Programmatic, regulatory, safety and ethical considerationsexternal icon. Vaccine. 2019 May 31; 37(25): 3267-3277. Epub 2019 May 6.

Su JR, Moro PL, Ng CS, Lewis PW, Said MA, Cano MV. Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016.external icon J Allergy Clin Immunol. 2019 Apr;143(4):1465-1473. Epub 2019 Jan 14.

Haber P, Moro PL, Ng C, Dores GM, Lewis P, Cano M. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.external icon Vaccine. 2019 Mar 7;37(11):1516-1520. Epub 2019 Feb 7.

Hesse EM, Shimabukuro TT, Su JR, et al. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018. MMWR Morb Mortal Wkly Rep 2019;68:91–94.

Landazabal CS, Moro PL, Lewis P, Omer SB. Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017external icon. Vaccine. 2019 Feb 21;37(9):1229-1234. Epub 2019 Jan 16.

Suragh TA, Lewis P, Arana J, Mba-Jonas A, Li R, Stewart B, Shimabukuro TT, Cano M. Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.external icon Br J Clin Pharmacol. 2018 Dec;84(12):2928-2932. Epub 2018 Sep 21.

Moro PL, Lewis P, Cano M Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006-2017 – Correspondenceexternal icon Travel Medicine and Infectious Disease 2018 Oct. ISSN 1477-8939.

Shimabukuro TT, Miller ER, Strikas RA, Hibbs BF, Dooling K, Goud R, Cano MV Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine — United States, 2017–2018.external icon MMWR Morb Mortal Wkly Rep 2018;67:585–586.

Moro PL, Perez-Vilar S, Lewis P, Bryant-Geneview M, Kamiya H, Cano M Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccinesexternal icon Pediatrics Jul 2018, 142 (1)e20174171.

Haber P, Amin M, Ng C, Weintraub E, McNeil MM Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016external icon, Human Vaccines & Immunotherapeutics, 2018 Jul 11;14(11); 2755-2759

Walker WL, Hills SL, Miller ER, Fischer M, Rabe IB. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016external icon. Vaccine. 2018 Jul 5;36(29):4369-4374. Epub 2018 Jun 8.

Su JR, Ng C, Lewis PW, Cano MV. Adverse events after vaccination among HIV-positive persons, 1990-2016.external icon PLoS One. 2018 Jun 19:13(6); e0199229. eCollection 2018.

Miller ER, Lewis P, Shimabukuro TT, Su J, Moro P, Woo EJ, Jankosky C, Cano M. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015Externalexternal icon. Hum Vaccin Immunother. 2018 May 18;14(8):1963-1969. Epub 2018 Mar 26.

Arana JE, Harrington T, Cano M, Lewis P, Mba-Jonas A, Rongxia L, Stewart B, Markowitz LE, Shimabukuro TT. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015Externalexternal icon. Vaccine. 2018 Mar 20;36(13):1781-1788. Epub 2018 Feb 21.

Haber P, Moro PL, Ng C, Lewis PW, Hibbs B, Schillie SF, Nelson NP, Li R, Stewart B, Cano MV. Safety of Currently Licensed Hepatitis B Surface Antigen Vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.external icon Vaccine. 2018 Jan 25;26(4):559-564.

Hibbs BF, Miller E, Shi J, Smith K, Lewis P, Shimabukuro TT. Safety of Vaccines That Have Been Kept Outside of Recommended Temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.external icon Vaccine. 2018 Jan 25;36(4):553-558.

Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018 Jan 12; 67(No. RR-1): 1–31.

Moro PL, Zheteyeva WY, Barash F, Lewis P, Cano M. Assessing the Safety of Hepatitis B Vaccination During Pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.external icon Vaccine. 2018 Jan 2;26(1):50-54.

Hibbs BF, Miller E, Shi J, Smith K, Lewis P, Shimabukuro TT. Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012external icon. Vaccine. 2018 Jan 25;36(4):553-558. Epub 2017 Dec 14.

Haber P, Moro PL, Ng C, Lewis PW, Hibbs B, Schillie SF, Nelson NP, Li R, Stewart B, Cano MV. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015external icon. Vaccine. 2018 Jan 25;36(4):559-564. Epub 2017 Dec 11.

Loharikar A, Suragh TA, MacDonald NE, Balakrishnan MR, Benes O, Lamprianou S, Hyde TB, McNeil MM. Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illnessexternal icon. Vaccine. 2018 Jan 4;36(2):299-305. Epub 2017 Nov 29.

Moro PL, Zheteyeva Y, Barash F, Lewis P, Cano M. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016external icon. Vaccine. 2018 Jan 2;36(1):50-54. Epub 2017 Nov 27.

Arana J, Mba-Jonas A, Jankosky C, Lewis P, Moro PL, Shimabukuro TT, Cano M. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting Systemexternal icon. J Adolesc Health. 2017 Nov;61 (5) :577-582.

Arana J, Mba-Jonas A, Jankosky C, Lewis P, Moro PL, Shimabukuro TT, Cano M. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.external icon J Adolesc Health. 2017 Nov;61(5):577-582.

Izurieta HS, Moro PL, Chen RT. Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?external icon Vaccine. 2018 Jan 8;36(3):345-346. Epub 2017 Oct 21.

Woo EJ, Moro PL, Cano M, Jankosky C. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.external icon Vaccine. 2017 Oct 9;35(42):5618-5621. Epub 2017 Sep 5.

Moro PL, Cragan J, Lewis P, Sukumaran L. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.external icon Birth Defects Res. 2017 Jul 17;109(13):1057-1062.

Suragh TA, Miller ER, Hibbs BF, Winiecki SK, Zinderman C, Shimabukuro TT. Cognitive testing to evaluate revisions to the Vaccine Adverse Event Reporting System (VAERS) reporting form.external icon Vaccine. 2017 Apr 25;35(18):2295-2297. Epub 2017 Mar 25.

Myers TR, McNeil MM, Ng CS, Li R, Lewis PW, Cano MV. Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015. external iconVaccine. 2017 Mar 27;35(14):1758-1763. Epub 2017 Mar 3.

Su JR, Leroy Z, Lewis PW, Haber P, Marin M, Leung J, Woo EJ, Shimabukuro TT. Safety of Second-Dose Single-Antigen Varicella Vaccine.external icon Pediatrics. 2017 Mar;139(3). Epub 2017 Feb 7.

Moro PL, Sukumaran L. Cholera vaccination: pregnant women excluded no more.external icon Lancet Infect Dis. 2017 May;17(5):469-470. Epub 2017 Feb 2. No abstract available.

Moro P, Baumblatt J, Lewis P, Cragan J, Tepper N, Cano M. Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.external icon Drug Saf. 2017 Feb;40(2):145-152.

McNeil MM, Hibbs BF, Miller ER, Cano MV. Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine – United States, 2017.external icon MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):109-110. No abstract available.

Haber P, Arana J, Pilishvili T, Lewis P, Moro PL, Cano M. Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.external icon Vaccine. 2016 Dec 7;34(50):6330-6334. Epub 2016 Nov 9.

Chen RT, Moro PL, Bauwens J, Bonhoeffer J. Obstetrical and neonatal case definitions for immunization safety data.external icon Vaccine. 2016 Dec 1;34(49):5991-5992. Epub 2016 Aug 20. No abstract available.

Moro PL, Woo EJ, Paul W, Lewis P, Petersen BW, Cano M. Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.external icon PLoS Negl Trop Dis. 2016 Jul 13;10(7):e0004846. eCollection 2016 Jul.

Moro PL, Li R, Haber P, Weintraub E, Cano M. Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.external icon Expert Opin Drug Saf. 2016 Sep;15(9):1175-83. Epub 2016 Jun 16. Review.

Miller ER, Moro PL, Cano M, Lewis P, Bryant-Genevier M, Shimabukuro TT. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.external icon Vaccine. 2016 May 27;34(25):2841-6. Epub 2016 Apr 15.

Haber P, Moro PL, Lewis P, Woo EJ, Jankosky C, Cano M. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.external icon Vaccine. 2016 May 11;34(22):2507-12. Epub 2016 Mar 23. Review.

Moro PL, Cragan J, Tepper N, Zheteyeva Y, Museru O, Lewis P, Broder K. Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015.external icon Vaccine. 2016 Apr 29;34(20):2349-53. Epub 2016 Mar 22.

Haber P, Moro PL, Ng C, Lewis PW, Hibbs B, Schillie SF, Nelson NP, Li R, Stewart B, Cano MV. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.external icon Vaccine. 2018 Jan 25;36(4):559-564. Epub 2017 Dec 11.

Su JR, Leroy Z, Lewis PW, Haber P, Marin M, Leung J, Woo EJ, Shimabukuro TT. Safety of Second-Dose Single-Antigen Varicella Vaccine.external icon Pediatrics. 2017 Mar;139(3). Epub 2017 Feb 7.

Su JR, Miller ER, Duffy J, Baer BM, Cano MV. Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine–United States, March 1, 2010-September 22, 2015.external icon MMWR Morb Mortal Wkly Rep. 2016 Feb 19;65(6):161-2. Erratum in: Errata: Vol. 65, No. 6external icon. [MMWR Morb Mortal Wkly Rep. 2016].

Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N. Prevention and control of haemophilus influenzae type b disease: Recommendations of the advisory committee on immunization practices (ACIP) pdf icon[PDF – 20 pages]. MMWR. 2014 Feb 28;63(RR-01):1-14.
Haber P, Moro PL, McNeil MM, Lewis P, Woo EJ, Hughes H, et al. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013external icon. Vaccine. 2014 Nov 12;32(48):6499-504.
Haber P, Moro PL, McNeil MM, Lewis P, Woo EJ, Hughes H, et al. Post-licensure surveillance of trivalent live attenuated influenza vaccine in children aged 2-18 years, Vaccine Adverse Event Reporting System (VAERS), United States, July 2005-June 2012external icon. J Ped Infect Dis. Epub 2014 May 7.
Hibbs BF, Miller ER, Shimabukuro T. Notes from the field: Rotavirus vaccine administration errors-United States, 2006-2013. MMWR. 2014;63(4):81.
McNeil MM, Cano M, Miller ER, Petersen BW, Engler RJ, Bryant-Genevier MG. Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting Systemexternal icon. Vaccine. 2014 Aug 20;32(37):4758-65.
Moro PL, Museru OI, Niu M, Lewis P, Broder K. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant womenexternal icon. Am J Obstet Gynecol. 2014 Jun;210(6):561.e1-6.

Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, et al. Intussusception after Rotavirus Vaccines—United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2012external icon. Pediatrics. 2013 Jun;131(6):1042-9.
Moro PL, Harrington T, Shimabukuro T, Cano M, Museru OI, Menschik D, et al. Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013external icon. Vaccine. 2013 Oct 9;31(43):4984-7.
Zheteyeva Y, Moro PL, Yue X, Broder K. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: A review of the Vaccine Adverse Event Reporting Systemexternal icon. Am J Obstet Gynecol. 2013 Jun;208(6):478.e1-6.

Broder KR, Martin DB, Vellozzi C. In the heat of a signal: Responding to a vaccine safety signal for febrile seizures after 2010–11 influenza vaccine in young children, United Statesexternal icon. Vaccine. 2012;30(11):2032-2034.
Leroy Z, Broder K, Menschik D, Shimabukuro T, Martin D. Febrile seizures after 2010–2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting systemexternal icon. Vaccine. 2012;30(11):2020-3.
Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancyexternal icon. Expert Rev Vaccines. 2012 Aug;11(8):911-21.
Moro PL, Arana J, Cano M, Menschik D, Yue Lewis P, Haber P, et al. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010–31 December 2010external icon. Clin Infect Dis.2012; 54(11):1608-14. Epub 2012 Mar 22.
Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant womenexternal icon. Am J Obstet Gynecol. 2012 Jul; 207(1):59.e1-7. Epub 2012 May 14.

Haber P, Iskander J, Walton K, Campbell SR, Kohl KS. Internet-Based Reporting to the Vaccine Adverse Event Reporting System: A More Timely and Complete Way for Providers to Support Vaccine Safetyexternal icon. Pediatrics. 2011; 127 Suppl 1: S39-44. Epub 2011 Apr 18.
Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting Systemexternal icon. Am J Obstet Gynecol. 2011; 205(5):473.e1-9. Epub 2011 Jun 21.
Moro PL, Yue X, Lewis P, Haber P, Broder K. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010external icon. Vaccine. 2011;29(50):9404-8. Epub 2011 Sep 13.
Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009external icon. Am J Obstet Gynecol. 2011 Feb; 204(2):146.e1-7. Epub 2010 Oct 20.
Slade BA, Gee J, Broder KR, Vellozzi C. Comment on the contribution by Souayah et al., “Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009”external icon. Vaccine. 2011; 29(5):865-6. Epub 2010 Nov 25.
Woo EJ, Wise RP, Menschik D, Shadomy SV, Iskander J, Beeler J, et al. Thrombocytopenia after vaccination: Case reports to the US Vaccine Adverse Event Reporting System, 1990-2008external icon. Vaccine. 2011;29(6):1319-23. Epub 2010 Nov 30.

Huang WT, Chang S, Miller ER, Woo EJ, Hoffmaster AR, Gee JE, et al. Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines–United States, 2007-2008external icon. Pharmacoepidemiol and Drug Saf. 2010;19(3):306-10.
Lindsey NP, Staples JE, Jones JF, Sejvar JJ, Griggs A, Iskander J, et al. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009external icon.Vaccine. 2010;29(1):58-64. Epub 2010 Nov 4.
McNeil MM, Broder KR, Vellozzi C, DeStefano F. Risk of fatal adverse events after H1N1 influenza vaccine: Limitations of passive surveillance dataexternal icon. Clin Infect Dis. 2010;51(7):871-2; author reply 872-3.
Muhammad RD, Haber P, Broder KR, Leroy Z, Ball R, Braun MM, et al. Adverse events following trivalent inactivated influenza vaccination in children: Analysis of the Vaccine Adverse Event Reporting Systemexternal icon. Pediatr Infect Dis J. 2010 Oct 29. [Epub ahead of print]
Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010external icon. Vaccine. 2010;28(45):7248-55. Epub 2010 Sep 16.
Wong C, Krashin J, Rue-Cover A, Saraiya M, Unger E, Calugar A, et al. Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS)external icon. J Womens Health (Larchmt). 2010 Mar;19(3):365-70.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndromeexternal icon. Drug Saf.2009; 32(4):309-23.
Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, et al. Kawasaki disease after vaccination: Reports to the vaccine adverse event reporting system 1990-2007external icon. Pediatr Infect Dis J. 2009;28(11):943-7.
Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; et al. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007external icon. Vaccine. 2009;27(2):290-7. Epub 2008 Nov 6.
Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: A review of the available evidenceexternal icon. Expert Rev Vaccines. 2009;8(11):1555-64.
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccineexternal icon. JAMA. 2009;302(7):750-7.
Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoringexternal icon. Vaccine. 2009 Mar 26; 27(15):2114-20. Epub 2009 Feb 6.

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003external icon. Vaccine. 2008;26(9):1166-72. Epub 2008 Jan 22.
Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, et al. Safety of varicella vaccine after licensure in the United States: Experience from reports to the vaccine adverse event reporting system, 1995-2005external icon. J Infect Dis. 2008;197 Suppl 2:S170-7.
Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007external icon. Pediatrics. 2008;121(6):1206-12.
Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, et al. Adverse event reports following yellow fever vaccinationexternal icon. Vaccine. 2008;26(48):6077-82. Epub 2008 Sep 20.
McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccineexternal icon. Vaccine. 2008;26(3):427-9. Epub 2007 Nov 29.
Sutherland A, Izurieta H, Ball R, Braun MM, Miller ER, Broder KR, et al. Syncope after vaccination–United States, January 2005-July 2007. MMWR. 2008 May 2;57(17):457-60.

Belongia E, Izurieta H, Braun MM, Ball R, Haber P, Baggs J, et al. Postmarketing monitoring of intussusception after RotaTeq vaccination–United States, February 1, 2006-February 15, 2007external icon. MMWR. 2007 Mar 16;56(10):218-22.
Haber P, Slade B, Iskander J. Guillain-Barré Syndrome (GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System (VAERS) in 2004 [Letter]external icon. Vaccine. 2007;25(48):8101. Epub 2007 Oct 1.
Woo EJ, Ball R, Landa R, Zimmerman AW, Braun MM; VAERS Working Group. Developmental regression and autism reported to the Vaccine Adverse Event Reporting Systemexternal icon. Autism.2007; 11(4):301-10.

CDC. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine–United States, October 2005-February 2006. MMWR. 2006 Apr 7;55(13):364-6.
DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; VAERS Team. Vaccination of yeast sensitive individuals: Review of safety data in the US vaccine adverse event reporting system (VAERS)external icon. Vaccine. 2006; 24(6):703-7. Epub 2005 Aug 9.
Iskander J, Pool V, Zhou W, English-Bullard R; VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting Systemexternal icon. Drug Saf. 2006;29(5):375-84.
Miller ER, Woo EJ. Time to prevent injuries from postimmunization syncopeexternal icon. Nursing. 2006; 36(12 Pt.1):20.
Varricchio F, Reed J; VAERS Working Group. Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS)external icon. South Med J. 2006 May;99(5):486-9.
Vellozzi C, Mitchell T, Miller E, Casey CG, Eidex RB, Hayes EB. Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: Eleven United States cases, 1996-2004external icon. Am J Trop Med Hyg. 2006 Aug;75(2):333-6.
Woo EJ, Ball R, Braun M, Clark T, Rosenstein Messonnier N, Wharton M, et al. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005–September 2006. MMWR. 2006 Oct 20;55(41):1120-4.
Woo EJ, Miller NB, Ball R; VAERS Working Group. Adverse events after hepatitis A B combination vaccineexternal icon. Vaccine. 2006;24(14):2685-91. Epub 2005 Nov 9.

Izurieta HS, Haber P, Wise RP, Iskander J, Pratt D, Mink C, et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccineexternal icon. JAMA. 2005;294(21):2720-5. Erratum in: JAMA. 2005 Dec 28;294(24):3092.
McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, etc. Adverse events after inactivated influenza vaccination among children less than 2 years of age: Analysis of reports from the vaccine adverse event reporting system, 1990-2003external icon. Pediatrics. 2005;115(2):453-60.

Begier EM, Burwen DR, Haber P, Ball R; Vaccine Adverse Event Reporting System Working Group. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002external icon. Clin Infect Dis. 2004;38(6):771-9. Epub 2004 Feb 26.
Begier EM, Langford CA, Sneller MC, Wise RP, Ball R; VAERS Working Group. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): Implications for assessment of suspected vaccine-provoked vasculitisexternal icon. J Rheumatol. 2004;31(11):2181-8.
Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain-Barré syndrome following influenza vaccinationexternal icon. JAMA. 2004; 292(20):2478-81.
Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: More than intussusception alone? external iconPediatrics. 2004;113(4):e353-9.
Iskander JK, Miller ER, Chen RT. The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safetyexternal icon. Pediatr Ann. 2004;33(9):599-606.
Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting Systemexternal icon. Pediatr Infect Dis J. 2004 Apr;23(4):287-94.
Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, et al. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccineexternal icon. JAMA. 2004;292(14):1702-10.
Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT; VAERS Working Group. A potential signal of Bell’s palsy after parenteral inactivated influenza vaccines: Reports to the Vaccine Adverse Event Reporting System (VAERS)–United States, 1991-2001external icon.Pharmacoepidemiol Drug Saf. 2004;13(8):505-10.

Lloyd JC, Haber P, Mootrey GT, Braun MM, Rhodes PH, Chen RT. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: Data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997external icon. Vaccine. 2003;21(25-26):3746-50.

Lathrop SL, Ball R, Haber P, Mootrey GT, Braun MM, Shadomy SV, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000external icon. Vaccine. 2002;20(11-12):1603-8.

Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team. Enhancing vaccine safety surveillance: A capture-recapture analysis of intussusception after rotavirus vaccinationexternal icon. Am J Epidemiol. 2001 Dec 1;154(11):1006-12.
Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M. Intussusception among recipients of rotavirus vaccine: Reports to the vaccine adverse event reporting systemexternal icon. Pediatrics. 2001;107(6):E97.
Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)–United States, 1991-2001external icon. MMWR Surveill Summ.2003 Jan 24; 52(1):1-24. Erratum in: MMWR. 2003 Feb 14; 52(06):113.

Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS, VAERS Working Group. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years’ data from the Vaccine Adverse Event Reporting System (VAERS)external icon. Pediatrics. 2000;106(4):E51.
Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese Encephalitis vaccination: Review of post-marketing surveillance data from Japan and the United Statesexternal icon. Vaccine. 2000;18(26):2963-9.
Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, et al. Post licensure safety surveillance for varicella vaccineexternal icon. JAMA. 2000;284:1271-9.